

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.80297803 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.47240975 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.47240975 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.47240975 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.47240975 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.47240975 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.47240975 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.92299149 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.65850039 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.53366295 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.53366295 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.30915782 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 4.27293756 |
| 14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.18372536 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.15705613 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.13043009 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 4.10942269 |
| 18 | response to peptidoglycan (GO:0032494) | 4.07575947 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 4.06701157 |
| 20 | positive regulation of antigen processing and presentation (GO:0002579) | 3.95512412 |
| 21 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.75844518 |
| 22 | response to host immune response (GO:0052572) | 3.70690564 |
| 23 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.70690564 |
| 24 | microglial cell activation (GO:0001774) | 3.53250337 |
| 25 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.52001757 |
| 26 | respiratory burst (GO:0045730) | 3.47399677 |
| 27 | pinocytosis (GO:0006907) | 3.45617477 |
| 28 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.38113423 |
| 29 | regulation of antigen processing and presentation (GO:0002577) | 3.37348019 |
| 30 | response to host (GO:0075136) | 3.36368534 |
| 31 | response to host defenses (GO:0052200) | 3.36368534 |
| 32 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.36368534 |
| 33 | neutrophil activation (GO:0042119) | 3.35180743 |
| 34 | positive regulation of B cell differentiation (GO:0045579) | 3.29744486 |
| 35 | myeloid cell activation involved in immune response (GO:0002275) | 3.28895760 |
| 36 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.26881064 |
| 37 | response to type I interferon (GO:0034340) | 3.26504721 |
| 38 | response to muramyl dipeptide (GO:0032495) | 3.25330250 |
| 39 | macrophage activation (GO:0042116) | 3.24580351 |
| 40 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.24069311 |
| 41 | cellular response to type I interferon (GO:0071357) | 3.23849877 |
| 42 | type I interferon signaling pathway (GO:0060337) | 3.23849877 |
| 43 | granulocyte activation (GO:0036230) | 3.23759491 |
| 44 | cellular extravasation (GO:0045123) | 3.22247650 |
| 45 | detection of other organism (GO:0098543) | 3.17900681 |
| 46 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.13668243 |
| 47 | regulation of T cell tolerance induction (GO:0002664) | 3.11927641 |
| 48 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.09215870 |
| 49 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.06092234 |
| 50 | cellular response to zinc ion (GO:0071294) | 3.03860697 |
| 51 | regulation of tolerance induction (GO:0002643) | 3.03092149 |
| 52 | response to interferon-alpha (GO:0035455) | 3.00588712 |
| 53 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.00476695 |
| 54 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.99205200 |
| 55 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.98858650 |
| 56 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.98788643 |
| 57 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.98619433 |
| 58 | B cell mediated immunity (GO:0019724) | 2.97406569 |
| 59 | detection of molecule of bacterial origin (GO:0032490) | 2.96863016 |
| 60 | defense response to protozoan (GO:0042832) | 2.96309938 |
| 61 | positive regulation of interferon-beta production (GO:0032728) | 2.95307572 |
| 62 | positive regulation of mast cell degranulation (GO:0043306) | 2.95242791 |
| 63 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.95242791 |
| 64 | negative regulation of T cell mediated immunity (GO:0002710) | 2.95031451 |
| 65 | response to interferon-beta (GO:0035456) | 2.94883479 |
| 66 | regulation of leukocyte degranulation (GO:0043300) | 2.93174571 |
| 67 | leukocyte aggregation (GO:0070486) | 2.92956300 |
| 68 | regulation of B cell differentiation (GO:0045577) | 2.88315084 |
| 69 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.85422887 |
| 70 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.85364897 |
| 71 | response to protozoan (GO:0001562) | 2.83730620 |
| 72 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.81325498 |
| 73 | negative regulation of cell killing (GO:0031342) | 2.81325498 |
| 74 | regulation of mast cell activation (GO:0033003) | 2.80345557 |
| 75 | regulation of gamma-delta T cell activation (GO:0046643) | 2.80242013 |
| 76 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.80011899 |
| 77 | detection of external biotic stimulus (GO:0098581) | 2.78756158 |
| 78 | monocyte chemotaxis (GO:0002548) | 2.78573328 |
| 79 | response to interleukin-15 (GO:0070672) | 2.76836230 |
| 80 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.76828618 |
| 81 | negative regulation of interleukin-17 production (GO:0032700) | 2.76492324 |
| 82 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.76305356 |
| 83 | myeloid dendritic cell activation (GO:0001773) | 2.76266156 |
| 84 | myeloid leukocyte activation (GO:0002274) | 2.74719932 |
| 85 | regulation of mast cell degranulation (GO:0043304) | 2.74338683 |
| 86 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.73953605 |
| 87 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.73943540 |
| 88 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.73901504 |
| 89 | negative regulation of innate immune response (GO:0045824) | 2.73874853 |
| 90 | neutrophil mediated immunity (GO:0002446) | 2.73348450 |
| 91 | negative regulation of interleukin-12 production (GO:0032695) | 2.73119730 |
| 92 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.71650831 |
| 93 | I-kappaB phosphorylation (GO:0007252) | 2.70815757 |
| 94 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.70740059 |
| 95 | cellular response to interferon-beta (GO:0035458) | 2.70520070 |
| 96 | positive regulation of macrophage differentiation (GO:0045651) | 2.70201280 |
| 97 | myeloid dendritic cell differentiation (GO:0043011) | 2.70127676 |
| 98 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.69340248 |
| 99 | negative regulation of interleukin-6 production (GO:0032715) | 2.68158286 |
| 100 | cellular response to interferon-gamma (GO:0071346) | 2.66846614 |
| 101 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.65998824 |
| 102 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.65947636 |
| 103 | B cell receptor signaling pathway (GO:0050853) | 2.65904134 |
| 104 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.65821122 |
| 105 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.65337567 |
| 106 | positive regulation of mast cell activation (GO:0033005) | 2.64893620 |
| 107 | cellular response to interleukin-15 (GO:0071350) | 2.64520716 |
| 108 | NIK/NF-kappaB signaling (GO:0038061) | 2.62644260 |
| 109 | germinal center formation (GO:0002467) | 2.62613114 |
| 110 | positive regulation of type 2 immune response (GO:0002830) | 2.62373265 |
| 111 | leukocyte degranulation (GO:0043299) | 2.60221613 |
| 112 | response to interferon-gamma (GO:0034341) | 2.59932071 |
| 113 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.59712550 |
| 114 | mast cell activation (GO:0045576) | 2.59611233 |
| 115 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.59588264 |
| 116 | negative regulation of mast cell activation (GO:0033004) | 2.58838803 |
| 117 | detection of bacterium (GO:0016045) | 2.58725278 |
| 118 | dendritic cell differentiation (GO:0097028) | 2.58322583 |
| 119 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.57867334 |
| 120 | superoxide anion generation (GO:0042554) | 2.57077037 |
| 121 | detection of biotic stimulus (GO:0009595) | 2.56205333 |
| 122 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.54945973 |
| 123 | leukocyte cell-cell adhesion (GO:0007159) | 2.54035505 |
| 124 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.53584619 |
| 125 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.53385219 |
| 126 | T-helper 1 type immune response (GO:0042088) | 2.53253430 |
| 127 | T cell migration (GO:0072678) | 2.53021314 |
| 128 | regulation of mononuclear cell migration (GO:0071675) | 2.52804535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.65523724 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.36770841 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.07916291 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.83767179 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.75106665 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.69404506 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.69158125 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.55751127 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.53455318 |
| 10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.39809298 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.37902091 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.05163436 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.88940028 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.58893097 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.55043243 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.54033422 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.46861933 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.45609728 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.43481545 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.33461693 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.21956332 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.21585517 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19297633 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.12117805 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.11182607 |
| 26 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.99398473 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.98285103 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.94559500 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.94497888 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.93898758 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91693060 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.82976587 |
| 33 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.82844373 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.82132850 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.82013150 |
| 36 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.77588538 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74462859 |
| 38 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.72665568 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72047569 |
| 40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.67550975 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66437807 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62972139 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.62725205 |
| 44 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58971968 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58304779 |
| 46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54313145 |
| 47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53499471 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.52044351 |
| 49 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51321698 |
| 50 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.49396954 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48086139 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.47889314 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45423919 |
| 54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42673895 |
| 55 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.40235630 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39112418 |
| 57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33382859 |
| 58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30687527 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.30146523 |
| 60 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.28144406 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27891499 |
| 62 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27279897 |
| 63 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26279066 |
| 64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25554155 |
| 65 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24197032 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23743117 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21839427 |
| 68 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.19524462 |
| 69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18298719 |
| 70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12402304 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12394986 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12226336 |
| 73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11078746 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10161248 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09739649 |
| 76 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08320718 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07556085 |
| 78 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07465832 |
| 79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07178294 |
| 80 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06705582 |
| 81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05822841 |
| 82 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05442429 |
| 83 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03525790 |
| 84 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01121597 |
| 85 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01111778 |
| 86 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.00495728 |
| 87 | MYC_22102868_ChIP-Seq_BL_Human | 0.99904928 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 0.99751954 |
| 89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99166747 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97034177 |
| 91 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96805766 |
| 92 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.96304904 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94225278 |
| 94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92197165 |
| 95 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89193066 |
| 96 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89079322 |
| 97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88717545 |
| 98 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86721725 |
| 99 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85786851 |
| 100 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.85786851 |
| 101 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85750889 |
| 102 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84805495 |
| 103 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84786331 |
| 104 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84690664 |
| 105 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84394652 |
| 106 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.84279582 |
| 107 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84260367 |
| 108 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83818844 |
| 109 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.83565550 |
| 110 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82547525 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82280207 |
| 112 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.80721604 |
| 113 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.80503941 |
| 114 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.78045191 |
| 115 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.77373924 |
| 116 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.77147523 |
| 117 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.77014884 |
| 118 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.76736026 |
| 119 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.76723600 |
| 120 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.75715607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.92392855 |
| 2 | MP0009785_altered_susceptibility_to | 3.11523455 |
| 3 | MP0003436_decreased_susceptibility_to | 3.01914467 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.97946747 |
| 5 | MP0003724_increased_susceptibility_to | 2.78253948 |
| 6 | MP0002419_abnormal_innate_immunity | 2.77014660 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.76854264 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.67131913 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.61402301 |
| 10 | MP0003303_peritoneal_inflammation | 2.60779695 |
| 11 | MP0005025_abnormal_response_to | 2.56172226 |
| 12 | MP0006082_CNS_inflammation | 2.54766100 |
| 13 | MP0005671_abnormal_response_to | 2.52377421 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.39441200 |
| 15 | MP0001790_abnormal_immune_system | 2.37289382 |
| 16 | MP0005387_immune_system_phenotype | 2.37289382 |
| 17 | MP0000685_abnormal_immune_system | 2.31362241 |
| 18 | MP0001800_abnormal_humoral_immune | 2.28714806 |
| 19 | * MP0002723_abnormal_immune_serum | 2.15543857 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.13270178 |
| 21 | MP0004510_myositis | 2.10388080 |
| 22 | MP0001819_abnormal_immune_cell | 2.08633651 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.08121828 |
| 24 | MP0009278_abnormal_bone_marrow | 2.00043768 |
| 25 | MP0000343_altered_response_to | 1.99292404 |
| 26 | MP0003828_pulmonary_edema | 1.89263882 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.85618253 |
| 28 | MP0003172_abnormal_lysosome_physiology | 1.85371845 |
| 29 | * MP0002405_respiratory_system_inflammati | 1.82297522 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.78913548 |
| 31 | MP0001853_heart_inflammation | 1.78252770 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.73672384 |
| 33 | * MP0001845_abnormal_inflammatory_respons | 1.67722857 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.65891551 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.65891551 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.63559244 |
| 37 | * MP0010155_abnormal_intestine_physiology | 1.62123918 |
| 38 | MP0002139_abnormal_hepatobiliary_system | 1.61677946 |
| 39 | MP0001873_stomach_inflammation | 1.61535172 |
| 40 | MP0004947_skin_inflammation | 1.59915462 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.57358725 |
| 42 | MP0009840_abnormal_foam_cell | 1.55520159 |
| 43 | * MP0000716_abnormal_immune_system | 1.52246996 |
| 44 | MP0002006_tumorigenesis | 1.51294622 |
| 45 | MP0002398_abnormal_bone_marrow | 1.49402382 |
| 46 | MP0008260_abnormal_autophagy | 1.49053380 |
| 47 | * MP0008469_abnormal_protein_level | 1.48305994 |
| 48 | MP0005451_abnormal_body_composition | 1.45323817 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.44070470 |
| 50 | MP0009764_decreased_sensitivity_to | 1.40583638 |
| 51 | * MP0000689_abnormal_spleen_morphology | 1.35103029 |
| 52 | MP0003448_altered_tumor_morphology | 1.33050293 |
| 53 | * MP0002429_abnormal_blood_cell | 1.29611660 |
| 54 | MP0002396_abnormal_hematopoietic_system | 1.27395870 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.26056038 |
| 56 | MP0000858_altered_metastatic_potential | 1.23020381 |
| 57 | MP0005174_abnormal_tail_pigmentation | 1.22758399 |
| 58 | * MP0002722_abnormal_immune_system | 1.22193540 |
| 59 | MP0003763_abnormal_thymus_physiology | 1.21269474 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.21150172 |
| 61 | MP0002132_abnormal_respiratory_system | 1.19807088 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.18150483 |
| 63 | MP0003075_altered_response_to | 1.17122152 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.16451996 |
| 65 | MP0004147_increased_porphyrin_level | 1.16233224 |
| 66 | MP0004883_abnormal_blood_vessel | 1.15942576 |
| 67 | MP0005310_abnormal_salivary_gland | 1.15425696 |
| 68 | MP0001879_abnormal_lymphatic_vessel | 1.12428836 |
| 69 | MP0003566_abnormal_cell_adhesion | 1.11545786 |
| 70 | MP0004808_abnormal_hematopoietic_stem | 1.08092306 |
| 71 | MP0003279_aneurysm | 1.06159312 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 1.04910274 |
| 73 | MP0005166_decreased_susceptibility_to | 1.02109507 |
| 74 | MP0002277_abnormal_respiratory_mucosa | 1.01038139 |
| 75 | MP0008004_abnormal_stomach_pH | 1.00470701 |
| 76 | MP0000249_abnormal_blood_vessel | 0.99767039 |
| 77 | MP0004084_abnormal_cardiac_muscle | 0.99416672 |
| 78 | MP0002933_joint_inflammation | 0.98637358 |
| 79 | MP0005365_abnormal_bile_salt | 0.97730530 |
| 80 | MP0001958_emphysema | 0.96480034 |
| 81 | MP0006054_spinal_hemorrhage | 0.96452514 |
| 82 | MP0010368_abnormal_lymphatic_system | 0.95632411 |
| 83 | MP0000767_abnormal_smooth_muscle | 0.92567985 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.92070758 |
| 85 | MP0008438_abnormal_cutaneous_collagen | 0.91050703 |
| 86 | MP0005165_increased_susceptibility_to | 0.90569175 |
| 87 | MP0000371_diluted_coat_color | 0.90489278 |
| 88 | MP0003690_abnormal_glial_cell | 0.89781683 |
| 89 | MP0000569_abnormal_digit_pigmentation | 0.88648107 |
| 90 | MP0004130_abnormal_muscle_cell | 0.86962751 |
| 91 | MP0009763_increased_sensitivity_to | 0.86773587 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.86049877 |
| 93 | MP0003866_abnormal_defecation | 0.84310654 |
| 94 | * MP0000490_abnormal_crypts_of | 0.82173753 |
| 95 | MP0002254_reproductive_system_inflammat | 0.80811911 |
| 96 | MP0003186_abnormal_redox_activity | 0.79771854 |
| 97 | MP0001851_eye_inflammation | 0.79329093 |
| 98 | MP0005390_skeleton_phenotype | 0.79079962 |
| 99 | MP0005360_urolithiasis | 0.78698790 |
| 100 | MP0005085_abnormal_gallbladder_physiolo | 0.78192285 |
| 101 | MP0005164_abnormal_response_to | 0.78155462 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.76294916 |
| 103 | MP0001663_abnormal_digestive_system | 0.75006876 |
| 104 | MP0003045_fibrosis | 0.74768277 |
| 105 | MP0005319_abnormal_enzyme/_coenzyme | 0.74550370 |
| 106 | MP0003646_muscle_fatigue | 0.73019634 |
| 107 | MP0000604_amyloidosis | 0.72866763 |
| 108 | MP0005023_abnormal_wound_healing | 0.72855855 |
| 109 | MP0005385_cardiovascular_system_phenoty | 0.72120345 |
| 110 | MP0001544_abnormal_cardiovascular_syste | 0.72120345 |
| 111 | MP0009765_abnormal_xenobiotic_induced | 0.70327151 |
| 112 | MP0003091_abnormal_cell_migration | 0.69789112 |
| 113 | MP0010630_abnormal_cardiac_muscle | 0.69630127 |
| 114 | MP0004381_abnormal_hair_follicle | 0.69522457 |
| 115 | MP0003795_abnormal_bone_structure | 0.69043051 |
| 116 | MP0000703_abnormal_thymus_morphology | 0.68834283 |
| 117 | MP0005075_abnormal_melanosome_morpholog | 0.66542080 |
| 118 | * MP0000609_abnormal_liver_physiology | 0.64278281 |
| 119 | MP0003195_calcinosis | 0.63605997 |
| 120 | MP0003252_abnormal_bile_duct | 0.60537293 |
| 121 | MP0001542_abnormal_bone_strength | 0.59759517 |
| 122 | MP0002332_abnormal_exercise_endurance | 0.58145501 |
| 123 | MP0008874_decreased_physiological_sensi | 0.56785238 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.55597339 |
| 125 | MP0003453_abnormal_keratinocyte_physiol | 0.55385188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Recurrent abscess formation (HP:0002722) | 5.87872293 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.59297939 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.28234567 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 4.53586226 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 4.36832865 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.35368098 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.20189561 |
| 8 | Myositis (HP:0100614) | 4.09573196 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.07202018 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.06771392 |
| 11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.05925185 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.64633456 |
| 13 | Pustule (HP:0200039) | 3.50313819 |
| 14 | Orchitis (HP:0100796) | 3.44335960 |
| 15 | Dysostosis multiplex (HP:0000943) | 3.42255013 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 3.36131498 |
| 17 | Autoimmune thrombocytopenia (HP:0001973) | 3.33458065 |
| 18 | Chronic otitis media (HP:0000389) | 3.30641121 |
| 19 | Recurrent skin infections (HP:0001581) | 3.24962004 |
| 20 | Hematochezia (HP:0002573) | 3.23725921 |
| 21 | Spontaneous hematomas (HP:0007420) | 3.23635709 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.22008337 |
| 23 | Interstitial pulmonary disease (HP:0006530) | 3.17536328 |
| 24 | Axonal loss (HP:0003447) | 3.16031640 |
| 25 | Gingivitis (HP:0000230) | 3.14702153 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.11062462 |
| 27 | Optic neuritis (HP:0100653) | 3.11062462 |
| 28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.08228925 |
| 29 | Encephalitis (HP:0002383) | 3.04297372 |
| 30 | Obstructive lung disease (HP:0006536) | 3.02689261 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.02689261 |
| 32 | Petechiae (HP:0000967) | 2.90904313 |
| 33 | T lymphocytopenia (HP:0005403) | 2.88019714 |
| 34 | Recurrent viral infections (HP:0004429) | 2.84600899 |
| 35 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.83080758 |
| 36 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.83080758 |
| 37 | Abnormality of glycolipid metabolism (HP:0010969) | 2.83080758 |
| 38 | Glomerulonephritis (HP:0000099) | 2.82235514 |
| 39 | Stomatitis (HP:0010280) | 2.79104361 |
| 40 | Abnormality of the nasal mucosa (HP:0000433) | 2.78157661 |
| 41 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.77239487 |
| 42 | Mucopolysacchariduria (HP:0008155) | 2.77239487 |
| 43 | Abnormality of T cell number (HP:0011839) | 2.76767674 |
| 44 | Amyloidosis (HP:0011034) | 2.72123118 |
| 45 | Asymmetric septal hypertrophy (HP:0001670) | 2.71625110 |
| 46 | Vasculitis (HP:0002633) | 2.68979665 |
| 47 | Periodontitis (HP:0000704) | 2.66058294 |
| 48 | Purpura (HP:0000979) | 2.62271034 |
| 49 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.61126537 |
| 50 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.61126537 |
| 51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.61126537 |
| 52 | Cellulitis (HP:0100658) | 2.60156741 |
| 53 | Pulmonary infiltrates (HP:0002113) | 2.56229450 |
| 54 | Meningitis (HP:0001287) | 2.54988494 |
| 55 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.53766360 |
| 56 | Basal ganglia calcification (HP:0002135) | 2.48921099 |
| 57 | Increased IgM level (HP:0003496) | 2.45205710 |
| 58 | Prostate neoplasm (HP:0100787) | 2.45062913 |
| 59 | Osteomyelitis (HP:0002754) | 2.44261360 |
| 60 | Nasal polyposis (HP:0100582) | 2.43961499 |
| 61 | Pulmonary embolism (HP:0002204) | 2.42648355 |
| 62 | Chest pain (HP:0100749) | 2.40976483 |
| 63 | Episodic fever (HP:0001954) | 2.38868801 |
| 64 | Urticaria (HP:0001025) | 2.37705973 |
| 65 | Abnormality of T cells (HP:0002843) | 2.37434764 |
| 66 | Malnutrition (HP:0004395) | 2.36745374 |
| 67 | Myocardial infarction (HP:0001658) | 2.36462594 |
| 68 | Arterial thrombosis (HP:0004420) | 2.36077123 |
| 69 | Thick nail (HP:0001805) | 2.34502236 |
| 70 | Nephritis (HP:0000123) | 2.33836514 |
| 71 | Loss of speech (HP:0002371) | 2.33746794 |
| 72 | Anorexia (HP:0002039) | 2.32885443 |
| 73 | Thrombocytosis (HP:0001894) | 2.32107819 |
| 74 | Hemoptysis (HP:0002105) | 2.30773990 |
| 75 | IgM deficiency (HP:0002850) | 2.29791434 |
| 76 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.28823635 |
| 77 | Recurrent cutaneous fungal infections (HP:0011370) | 2.28823635 |
| 78 | Gangrene (HP:0100758) | 2.25065608 |
| 79 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.19265419 |
| 80 | Osteolytic defects of the hand bones (HP:0009699) | 2.19265419 |
| 81 | Disinhibition (HP:0000734) | 2.18636276 |
| 82 | Prolonged bleeding time (HP:0003010) | 2.17897610 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.16968837 |
| 84 | Abnormality of the pleura (HP:0002103) | 2.16954399 |
| 85 | Nausea (HP:0002018) | 2.15106168 |
| 86 | Granulocytopenia (HP:0001913) | 2.14812427 |
| 87 | Ventricular tachycardia (HP:0004756) | 2.14662660 |
| 88 | Recurrent bronchitis (HP:0002837) | 2.12682176 |
| 89 | Hepatosplenomegaly (HP:0001433) | 2.12592608 |
| 90 | Peritonitis (HP:0002586) | 2.11800990 |
| 91 | Panhypogammaglobulinemia (HP:0003139) | 2.11721233 |
| 92 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.10985715 |
| 93 | Abnormality of T cell physiology (HP:0011840) | 2.10464725 |
| 94 | Epistaxis (HP:0000421) | 2.09367130 |
| 95 | Leukocytosis (HP:0001974) | 2.08856065 |
| 96 | Gastrointestinal stroma tumor (HP:0100723) | 2.07434533 |
| 97 | Polyneuropathy (HP:0001271) | 2.06828116 |
| 98 | Esophageal neoplasm (HP:0100751) | 2.05686118 |
| 99 | Neoplasm of head and neck (HP:0012288) | 2.05686118 |
| 100 | Abnormality of the prostate (HP:0008775) | 2.00537624 |
| 101 | Keratoconjunctivitis sicca (HP:0001097) | 1.99019080 |
| 102 | Impaired platelet aggregation (HP:0003540) | 1.98530474 |
| 103 | Abnormal platelet function (HP:0011869) | 1.98530474 |
| 104 | Progressive neurologic deterioration (HP:0002344) | 1.97593643 |
| 105 | Glomerulopathy (HP:0100820) | 1.97188108 |
| 106 | Facial diplegia (HP:0001349) | 1.96357367 |
| 107 | Eosinophilia (HP:0001880) | 1.95363814 |
| 108 | Increased CSF protein (HP:0002922) | 1.94476822 |
| 109 | * Inflammation of the large intestine (HP:0002037) | 1.94400589 |
| 110 | Recurrent pneumonia (HP:0006532) | 1.93659883 |
| 111 | Premature loss of primary teeth (HP:0006323) | 1.93400941 |
| 112 | Thoracic kyphosis (HP:0002942) | 1.93003429 |
| 113 | Autoimmune hemolytic anemia (HP:0001890) | 1.91150494 |
| 114 | Increased serum ferritin (HP:0003281) | 1.90019236 |
| 115 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89459261 |
| 116 | Skin ulcer (HP:0200042) | 1.89329408 |
| 117 | Emphysema (HP:0002097) | 1.89261183 |
| 118 | Abnormality of the pericardium (HP:0001697) | 1.88783658 |
| 119 | Mucosal telangiectasiae (HP:0100579) | 1.87905582 |
| 120 | * Gastrointestinal inflammation (HP:0004386) | 1.86454631 |
| 121 | Acne (HP:0001061) | 1.85068651 |
| 122 | Hypochromic microcytic anemia (HP:0004840) | 1.84951809 |
| 123 | Esophageal varix (HP:0002040) | 1.84554432 |
| 124 | Increased IgE level (HP:0003212) | 1.83227973 |
| 125 | Chronic diarrhea (HP:0002028) | 1.80552390 |
| 126 | Keratoconjunctivitis (HP:0001096) | 1.80220849 |
| 127 | Hypergammaglobulinemia (HP:0010702) | 1.79798630 |
| 128 | Gingival bleeding (HP:0000225) | 1.78855735 |
| 129 | Abnormality of iron homeostasis (HP:0011031) | 1.78476524 |
| 130 | Tetraparesis (HP:0002273) | 1.78316681 |
| 131 | Albinism (HP:0001022) | 1.77231304 |
| 132 | Bone pain (HP:0002653) | 1.76767181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.34081005 |
| 2 | TBK1 | 3.14901828 |
| 3 | MAP4K1 | 3.08651995 |
| 4 | TGFBR2 | 3.05024430 |
| 5 | TYK2 | 3.03310074 |
| 6 | KIT | 3.00440799 |
| 7 | MAP3K14 | 2.94605329 |
| 8 | IRAK4 | 2.59212360 |
| 9 | IRAK3 | 2.39818167 |
| 10 | IKBKE | 2.35951525 |
| 11 | TXK | 2.28071554 |
| 12 | RIPK4 | 2.27045209 |
| 13 | JAK3 | 1.97020371 |
| 14 | TEC | 1.94339877 |
| 15 | ZAP70 | 1.94140863 |
| 16 | ERN1 | 1.93160215 |
| 17 | KDR | 1.81977099 |
| 18 | TTN | 1.79929611 |
| 19 | NME2 | 1.79891741 |
| 20 | JAK1 | 1.79068519 |
| 21 | IKBKB | 1.73047264 |
| 22 | CSF1R | 1.72560764 |
| 23 | BMPR2 | 1.68232422 |
| 24 | TNK2 | 1.62806389 |
| 25 | BTK | 1.60290370 |
| 26 | ACVR1B | 1.60069709 |
| 27 | PRPF4B | 1.59600575 |
| 28 | FLT3 | 1.56124473 |
| 29 | MAP2K3 | 1.55035436 |
| 30 | TAOK1 | 1.52005601 |
| 31 | ITK | 1.47796696 |
| 32 | CSK | 1.45932762 |
| 33 | NEK9 | 1.44345857 |
| 34 | PKN2 | 1.41799476 |
| 35 | STK10 | 1.41094323 |
| 36 | EPHB1 | 1.38216718 |
| 37 | MYLK | 1.38082390 |
| 38 | SYK | 1.33290626 |
| 39 | TAOK2 | 1.27988991 |
| 40 | TIE1 | 1.27831773 |
| 41 | PIM2 | 1.25774560 |
| 42 | LRRK2 | 1.25425713 |
| 43 | GRK7 | 1.23687906 |
| 44 | TESK2 | 1.18075357 |
| 45 | HCK | 1.14361538 |
| 46 | TRIB3 | 1.13532339 |
| 47 | LCK | 1.13022383 |
| 48 | MATK | 1.10159758 |
| 49 | LYN | 1.09842864 |
| 50 | MAP3K1 | 1.08459681 |
| 51 | MST4 | 1.07252172 |
| 52 | TRPM7 | 1.05603041 |
| 53 | PRKG2 | 1.04288225 |
| 54 | SIK3 | 1.03894067 |
| 55 | MAP3K3 | 1.02355910 |
| 56 | PIM1 | 1.01364268 |
| 57 | NLK | 1.01006130 |
| 58 | TAOK3 | 0.99038224 |
| 59 | RIPK1 | 0.98532353 |
| 60 | IRAK1 | 0.96949414 |
| 61 | PAK4 | 0.94655568 |
| 62 | CHUK | 0.92593172 |
| 63 | RPS6KA4 | 0.91054302 |
| 64 | PRKD2 | 0.87032814 |
| 65 | JAK2 | 0.86573578 |
| 66 | MARK3 | 0.86257526 |
| 67 | FES | 0.85064730 |
| 68 | PTK6 | 0.85032844 |
| 69 | MAP3K13 | 0.81403906 |
| 70 | FGFR4 | 0.81076146 |
| 71 | CAMK1D | 0.77124120 |
| 72 | PDK1 | 0.76713975 |
| 73 | CDC42BPA | 0.74350214 |
| 74 | PDPK1 | 0.70367215 |
| 75 | STK4 | 0.66138528 |
| 76 | TGFBR1 | 0.65775507 |
| 77 | MAP3K12 | 0.64458399 |
| 78 | FRK | 0.63185908 |
| 79 | MAP3K10 | 0.62083611 |
| 80 | FGFR3 | 0.61779912 |
| 81 | CAMKK2 | 0.61060590 |
| 82 | MAP2K6 | 0.59558900 |
| 83 | MAPKAPK3 | 0.59447405 |
| 84 | MAPK7 | 0.59354538 |
| 85 | MST1R | 0.59281593 |
| 86 | PRKCD | 0.58686082 |
| 87 | ADRBK2 | 0.58410209 |
| 88 | MAP3K11 | 0.57027763 |
| 89 | DMPK | 0.56558740 |
| 90 | GRK6 | 0.56042201 |
| 91 | ABL1 | 0.55580285 |
| 92 | MAP3K2 | 0.55574489 |
| 93 | KSR2 | 0.55020136 |
| 94 | EPHA3 | 0.54575978 |
| 95 | PRKCQ | 0.54057969 |
| 96 | LMTK2 | 0.54004138 |
| 97 | MAP3K6 | 0.53237045 |
| 98 | DDR2 | 0.51496831 |
| 99 | FYN | 0.49043049 |
| 100 | EGFR | 0.48907660 |
| 101 | STK24 | 0.48689404 |
| 102 | PIK3CA | 0.48360725 |
| 103 | HIPK2 | 0.46079634 |
| 104 | MAP2K2 | 0.45201972 |
| 105 | IRAK2 | 0.45107098 |
| 106 | IGF1R | 0.43618938 |
| 107 | SCYL2 | 0.43616759 |
| 108 | MAPKAPK2 | 0.43459490 |
| 109 | FGR | 0.41865612 |
| 110 | CLK1 | 0.41780610 |
| 111 | PIK3CG | 0.39752290 |
| 112 | MOS | 0.39685473 |
| 113 | YES1 | 0.39506577 |
| 114 | MAPK11 | 0.39395383 |
| 115 | GRK1 | 0.39163185 |
| 116 | PRKAA2 | 0.38226611 |
| 117 | MAPK12 | 0.37952357 |
| 118 | RPS6KA6 | 0.37542627 |
| 119 | MARK2 | 0.36392585 |
| 120 | CDK19 | 0.36280942 |
| 121 | EIF2AK2 | 0.35719850 |
| 122 | MAP3K5 | 0.35401999 |
| 123 | INSRR | 0.31841124 |
| 124 | DAPK2 | 0.31112547 |
| 125 | MAP3K7 | 0.29611946 |
| 126 | PTK2B | 0.29505302 |
| 127 | ABL2 | 0.28941775 |
| 128 | PRKD1 | 0.28798051 |
| 129 | DAPK3 | 0.27403971 |
| 130 | RPS6KC1 | 0.27358020 |
| 131 | RPS6KL1 | 0.27358020 |
| 132 | MUSK | 0.26866847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.17232085 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.98929818 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.53058379 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.46504042 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.41929469 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.33501105 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.29673970 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 2.24266395 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 2.23865912 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 2.20568306 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.19114025 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16951059 |
| 13 | Measles_Homo sapiens_hsa05162 | 2.06631292 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.97940740 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.94984744 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.93702073 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.92625550 |
| 18 | * Tuberculosis_Homo sapiens_hsa05152 | 1.85554294 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.79659700 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.79440053 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.79352740 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.76692847 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.75562394 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.69094316 |
| 25 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.66760075 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.62021830 |
| 27 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.60996981 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60772167 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.57379490 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.50755887 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.48915947 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.47419503 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.42712220 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.42536111 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.39127926 |
| 36 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.38542703 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.35988215 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.35667901 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32657526 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29306617 |
| 41 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26461212 |
| 42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26184709 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22176883 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.19700867 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08596862 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.05923542 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04565579 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.01377741 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 1.00464984 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97762264 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.93843037 |
| 52 | Amoebiasis_Homo sapiens_hsa05146 | 0.92702132 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.91722365 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.90092221 |
| 55 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89677125 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82395193 |
| 57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76563096 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73694376 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73313747 |
| 60 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72003746 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71469797 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68042637 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67563435 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67464021 |
| 65 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66113397 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65827014 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65701173 |
| 68 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62967798 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59686958 |
| 70 | Mineral absorption_Homo sapiens_hsa04978 | 0.59324363 |
| 71 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57698661 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55904595 |
| 73 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.55212861 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54522814 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54123729 |
| 76 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52734478 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.50576365 |
| 78 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.47158471 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.46861713 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46773534 |
| 81 | Focal adhesion_Homo sapiens_hsa04510 | 0.46149589 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45136654 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45118008 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43516512 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42491890 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39430797 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38961008 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.38688971 |
| 89 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.38366599 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37424218 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37038443 |
| 92 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.36586478 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.36114469 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35345530 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34967184 |
| 96 | Adherens junction_Homo sapiens_hsa04520 | 0.34318507 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34306779 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33851408 |
| 99 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.33718846 |
| 100 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.33129133 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32866976 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32051359 |
| 103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.31397042 |
| 104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.31085489 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30422745 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30354800 |
| 107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28100024 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.28075440 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27699383 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27416916 |
| 111 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.27144053 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26572692 |
| 113 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.25330705 |
| 114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25060385 |
| 115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23634993 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19514006 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18557795 |

